Company performance
Current Price
as of Jan 07, 2025$3.59
P/E Ratio
N/A
Market Cap
$3.11B
Loading...
Description
Shanghai Junshi Biosciences Co., Ltd. engages in the discovery, development, clinical research, and commercialization of biopharmaceutical drugs. Its products include toripalimab injection, UBP1211, JS002, and UBP1213. The company was founded by Zhuo Bing Zhang and Ji Kuan Shan on December 27, 2012 and is headquartered in Shanghai, China.
Metrics
Overview
- HQShanghai, SH
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- Ticker688180
- Price$3.588448-1.50%
Trading Information
- Market cap$3.11B
- Float36.13%
- Average Daily Volume (1m)5,283,405
- Average Daily Volume (3m)7,587,794
- EPS-$1.83
Company
- Revenue$1.76B
- Rev growth (1yr)53.68%
- Net income-$281.81M
- Gross margin76.04%
- EBITDA marginN/A
- EBITDAN/A
- EV$31.15B
- EV/Revenue17.66
- P/EN/A
- P/S14.91
- P/B4.26
Documents
Factset Street Account